Craig Hallum has recently initiated Cerus Corp (CERS) stock to Buy rating, as announced on April 12, 2024, according to Finviz. Earlier, on January 20, 2023, BTIG Research had reduced the stock from a Buy to Neutral. Stephens also reduced their rating with a price target of $3.75. Additionally, BTIG Research resumed Buy rating on October 8, 2020, with a target price of $9. Cantor Fitzgerald analysts, in their report published on June 16, 2020, also resumed Overweight rating and set a price target of $9 for Cerus Corp’s stock. Analyst ratings are significant because they provide insights into stock performance expectations, influencing investor decisions and market sentiment.
Sponsored
Cerus Corp (CERS) Stock Trading Recap
On Tuesday, Cerus Corp (CERS) stock saw a decline, ending the day at $1.7 which represents a decrease of $-0.04 or -2.30% from the prior close of $1.74. The stock opened at $1.71 and touched a low of $1.67 during the day, reaching a high of $1.75. The volume of shares traded was 0.89 million falling short of the average volume of 0.95 million.
CERS Stock Performance and Moving Averages
In recent trading, Cerus Corp (CERS) stock price has shown some volatility, fluctuating -5.56% over the last five trades and -24.78% over the past 30 trades. This represents a notable shift from earlier in the year. Over the last six months, the stock has risen by -3.41%, and it has plunged by 0.00% in the previous three months. Currently, CERS is trading at -12.12%, -19.82%, and -14.44% relative to its 20-Day, 50-Day, and 200-Day Simple Moving Averages, respectively.
As of the latest trading close, CERS, a Healthcare sector stock, is trading -34.24% below its 52-week high but remains 41.08% above its 52-week low. The Average True Range (ATR) (14 days) of 0.1 highlights the stock’s average volatility, providing insight into how much the price typically fluctuates. This measure is crucial for understanding potential price swings and assessing overall market risk.
Cerus Corp’s Profitability and Valuation Ratios
Cerus Corp’s profitability metrics reveal strong financial health. The company currently boasts an operating margin of -22.95% and a profit margin of -14.15%, with a gross margin of -3.41%. The profit margin, also known as the revenue ratio or gross profit ratio, measures how efficiently a company converts sales into net income; higher margins indicate greater profitability.
In terms of valuation, Cerus Corp’s market capitalization stands at $315.01 million. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market value. Additionally, the Price-to-Sales Ratio is 1.85, reflecting the market’s valuation of the company’s sales, while the Price-to-Book Ratio is 6.36, comparing the market value to the company’s book value.
Understanding Insider Trading
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 5.05% of Cerus Corp (CERS)’s shares, while financial institutions hold 75.95%.
Notable insider trades include Green Kevin Dennis, Chief Financial Officer at Cerus Corp (CERS), who sold 54272 shares on Sep 04 ’24, at $2.15 each, totaling $0.12 million. On Mar 14 ’24, Greenman William Mariner, President and CEO, sold 63611 shares for $2.02 each, amounting to $0.13 million. Additionally, on Mar 13 ’24, Greenman William Mariner sold 62315 shares at $2.06 each, generating $0.13 million.
